Quantum Computing in Drug Discovery Market Size to Reach USD 1,692 million by 2035

According to a recently published report by Roots Analysis, given the growing complexity of drug discovery process and the need to reduce time-to-market, the quantum computing in drug discovery market is well positioned for future growth, as quantum computing enables faster and more accurate simulation of complex molecular interactions as compared to classical computing methods.

Global Quantum Computing in Drug Discovery Market Overview

The global quantum computing in drug discovery market is expected to reach USD 1,692 million by 2035, growing at a CAGR of 18.7% during the forecast period till 2035.

Drug discovery has always been a time-consuming process. It involves various stages, such as target identification, validation, hit generation, hit to lead and lead optimization, followed by development processes including optimization and formulation, clinical trials and final approval by authorized regulatory bodies. Several technological advancements in the process of drug discovery, such as high-throughput screening, AI-driven molecular modeling, and CRISPR gene editing have simplified early-stage discovery, yet the overall process continues to be complex, expensive, and lengthy. It is worth noting that on an average, the drug discovery process takes 10-15 years and investments worth USD 4-5 billion to commercially launch a drug. In order to address these challenges, drug developers are shifting their focus from traditional techniques to the use of novel discovery techniques. Quantum computing has emerged to be one of the prominent technologies that assists the drug developers in selecting potential lead candidates, having the desired physiochemical and pharmacokinetic properties, without having to conduct extensive screening procedures. The quantum computing enabled drug discovery market is expected to grow rapidly in the coming years, primarily driven by the need to shorten drug development timelines and reduce R&D costs. Additionally, growth is fueled by the increasing complexity of novel drug molecules and the demand for more accurate, high-throughput molecular simulations.

Browse 115+ figures and ~125 market data tables spread across 250+ slides and detailed Table of Content on “Global quantum computing in drug discovery market (2nd Edition), till 2035 by Type Of Offering (Hardware, Service And Platform / Software), Drug Discovery Step (Target Identification / Validation, Hit Generation / Lead Identification And Lead Optimization), Target Therapeutic Area (Oncological Disorders, Musculoskeletal Disorders, Cardiovascular Disorders, Respiratory Disorders, Neurological Disorders, Gastrointestinal Disorders, Immunological Disorders, Endocrine Disorders, Ophthalmological Disorders, Blood-related Disorders, Dermatological Disorders, Infectious Diseases And Urinary Disorders), End Users (Pharma And Biotech Companies, Cros, And Research And Academic Institutes) And Geographical Regions (North America, Europe, Asia-pacific, Middle East And North Africa, And Latin America) and Key Players” here: https://www.rootsanalysis.com/reports/quantum-computing-in-drug-discovery.html

Market Drivers

Several factors are propelling global quantum computing in drug discovery market growth. A key driver is the increased need of novel drugs to treat diseases like cancer, cardiovascular disorders, metabolic diseases and many more. Quantum computing technologies provide a technical edge that boosts accuracy, helps in time optimization, enables faster scalability, and enhances efficiency in drug discovery process. As a result, more companies are expected to adopt quantum computing technologies, driving significant market expansion.

Market Restraints

While the global quantum computing in drug discovery market is experiencing substantial growth, there are certain restraints that can hinder the growth of this industry. One of the primary challenges is the technological complexity and variability of quantum computing systems which limits the adoption of quantum computing at a larger scale. Moreover, this industry requires enormous upfront financial investment in specialized infrastructure, controlled laboratory environments, cryogenic systems, and large-scale computational facilities. These factors collectively hamper market growth, acting as barriers to wider adoption and challenging the market’s ability to sustain its growth trajectory.

Growth Factors

Despite the aforementioned restraints, several growth factors continue to drive the global quantum computing in drug discovery market forward. One notable factor is the integration of artificial intelligence and machine learning in quantum computing technologies, which has significantly resulted in enhanced efficiency, quality, and agility across various processes. These technologies enable real-time process monitoring, predictive maintenance, and automated quality control, which minimizes the error rate in drug discovery process. Owing to these factors, it can be anticipated that the global quantum computing in drug discovery market will flourish remarkably in the foreseen future.

Global Quantum Computing in Drug Discovery Market Segments

Based on the type of offering, the market is segmented into hardware, service and platform / software.

• The hardware sub-segment led the global quantum computing in drug discovery market, capturing the largest revenue share of around 50% in the current year.
• Service sub-segment is anticipated to show the highest growth rate of 20.1%, during the forecast period.

Based on the drug discovery steps, the market is segmented into target identification / validation, hit generation / lead identification and lead optimization.

• The lead optimization sub-segment led the global quantum computing in drug discovery market, capturing the largest revenue share of around 50% in the current year.
• This is because lead optimization step transforms raw, often unsafe "hits" into viable, druggable preclinical candidates by enhancing potency, safety, and pharmacokinetic (ADMET) properties.

Based on the target therapeutic area, the market is segmented into oncological disorders, musculoskeletal disorders, cardiovascular disorders, respiratory disorders, neurological disorders, gastrointestinal disorders, immunological disorders, endocrine disorders, ophthalmological disorders, blood-related disorders, dermatological disorders, infectious diseases and urinary disorders.

• The oncological disorders sub-segment led the global quantum computing in drug discovery market, capturing the largest revenue share of around 20% in the current year. Further, it is worth highlighting that this segment is expected to grow at a higher annualized rate of 21.1%.
• This is primarily because of the rising prevalence of cancer and the need for novel drug candidates to reduce the mortality rate amongst population.

Based on the end users, the market is segmented into pharma and biotech companies, CROS and research and academic institutes.

• The pharma and biotech companies sub segment is expected to hold the majority share of global quantum computing in drug discovery market, capturing about 75% of revenue share in the current year.
• The CROs sub-segment is anticipated to be the fastest growing segment in this industry, with an annualized rate of 20.3% during the forecast period.

Based on the geographical region, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa and Latin America.

• North America dominated the global quantum computing in drug discovery market and accounted for the largest revenue share (>40%) in the current year.
• The Asia-Pacific sub-segment is anticipated to be the fastest growing segment in this industry, with an annualized rate of 21.3% during the forecast period.

Key Companies Profiled

The global quantum computing in drug discovery market report also includes detailed profiles of leading players (listed below) that are engaged in quantum computing in drug discovery domain:

• IBM
• IonQ
• Microsoft
• PASQAL
• Rigetti Computing
• Riverlane
• Xanadu
• Infleqtion
• Quandela
• Classiq
• QuEra Computing
• D-wave

You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/quantum-computing-in-drug-discovery/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in the market research. Having worked with over 1,500 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com